Recovery · May 14, 2024
TB-500: Systemic Tissue Remodeling Research
Summary
TB-500 is a synthetic fragment of Thymosin Beta-4 studied for actin binding, angiogenesis, and tissue remodeling.
Why It Matters
Where BPC-157 is studied as local, TB-500 is discussed as systemic. The two are commonly compared and stacked in injury-recovery research.
Key Findings
- Actin-monomer binding underpins much of the mechanism research.
- Angiogenesis and wound-healing animal models support the recovery narrative.
- Now on the WADA prohibited list.